NuGene International, Inc. (NUGN)

0.0107 +0.0009 (+9.18%) At close: 03:55PM EDT

NuGene International, Inc.

17 State Street
Suite 4000
New York, NY 10004
United States
980 432 8241
https://www.liventogroup.com

Sector(s): Technology
Industry: Software - Application
Full-time employees: 11

Key executives

Name	Title	Pay	Exercised	Year born
Mr. David Stybr	President, CEO & Director	144k	N/A	1984
Mr. Misha Henriksen	Chief Investment Officer	N/A	N/A	N/A
Mr. David Zich	Treasury & Secretary	N/A	N/A	1996

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Livento Group, Inc. engages in the film and television production business. It is also involved in the artificial intelligence and machine learning technology business; development and licensing of Elisee, a software product that can capture data and create predictive behavior based on client inputs that assist the client in establishing its investment portfolio; and real estate finance and development activities. The company was formerly known as NuGene International, Inc. and changed its name to Livento Group, Inc. in June 2022. Livento Group, Inc. is headquartered in New York, New York.

Corporate governance

NuGene International, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.